Table 2:

Freedom from diverse adverse outcomes for decellularized aortic homografts (DAH) within the ARISE Study and the ARISE Registry, both including children, compared with the Ross cohort published by David et al. [19] and a large Ross review published by Takkenberg et al. [2]

Freedom from (%)CohortAt 5 years (mean ± SD in %)At 10 years (mean ± SD in %)
DeathARISE(n=144)97.9 (1.0)n.a.
All DAH(n= 358)98.3 (0.7)95.7 (1.7)
Ross(n= 212) [19]98.697.6
Ross(n= 8523) [2]96.293.9
EndocarditisARISE96.4 (1.6)n.a.
All DAH97.8 (0.9)92.6 (3.1)
Ross10098.6
Rossn.a.n.a.
Explantation/Re-operationARISE93.5 (2.1)n.a.
All DAH92.4 (1.7)69.5 (6.5)a
Ross97.194.2
Ross(n= 6653) [2]92.180.9
Major bleedingARISE98.6 (1.0)n.a.
All DAH99.4 (0.4)98.8 ± 0.9
Rossn.a.n.a.
Rossn.a.n.a.
Thrombotic event/strokeARISE99.3 (0.1)n.a.
All DAH99.7 (0.3)94.4 (5.1)
Ross100100
Rossn.a.n.a.
Freedom from (%)CohortAt 5 years (mean ± SD in %)At 10 years (mean ± SD in %)
DeathARISE(n=144)97.9 (1.0)n.a.
All DAH(n= 358)98.3 (0.7)95.7 (1.7)
Ross(n= 212) [19]98.697.6
Ross(n= 8523) [2]96.293.9
EndocarditisARISE96.4 (1.6)n.a.
All DAH97.8 (0.9)92.6 (3.1)
Ross10098.6
Rossn.a.n.a.
Explantation/Re-operationARISE93.5 (2.1)n.a.
All DAH92.4 (1.7)69.5 (6.5)a
Ross97.194.2
Ross(n= 6653) [2]92.180.9
Major bleedingARISE98.6 (1.0)n.a.
All DAH99.4 (0.4)98.8 ± 0.9
Rossn.a.n.a.
Rossn.a.n.a.
Thrombotic event/strokeARISE99.3 (0.1)n.a.
All DAH99.7 (0.3)94.4 (5.1)
Ross100100
Rossn.a.n.a.
a

Freedom from explantation in all adult patients within the ARISE Registry was 72.8% (SD 10.0).

SD: standard deviation; n.a.: not available.

Table 2:

Freedom from diverse adverse outcomes for decellularized aortic homografts (DAH) within the ARISE Study and the ARISE Registry, both including children, compared with the Ross cohort published by David et al. [19] and a large Ross review published by Takkenberg et al. [2]

Freedom from (%)CohortAt 5 years (mean ± SD in %)At 10 years (mean ± SD in %)
DeathARISE(n=144)97.9 (1.0)n.a.
All DAH(n= 358)98.3 (0.7)95.7 (1.7)
Ross(n= 212) [19]98.697.6
Ross(n= 8523) [2]96.293.9
EndocarditisARISE96.4 (1.6)n.a.
All DAH97.8 (0.9)92.6 (3.1)
Ross10098.6
Rossn.a.n.a.
Explantation/Re-operationARISE93.5 (2.1)n.a.
All DAH92.4 (1.7)69.5 (6.5)a
Ross97.194.2
Ross(n= 6653) [2]92.180.9
Major bleedingARISE98.6 (1.0)n.a.
All DAH99.4 (0.4)98.8 ± 0.9
Rossn.a.n.a.
Rossn.a.n.a.
Thrombotic event/strokeARISE99.3 (0.1)n.a.
All DAH99.7 (0.3)94.4 (5.1)
Ross100100
Rossn.a.n.a.
Freedom from (%)CohortAt 5 years (mean ± SD in %)At 10 years (mean ± SD in %)
DeathARISE(n=144)97.9 (1.0)n.a.
All DAH(n= 358)98.3 (0.7)95.7 (1.7)
Ross(n= 212) [19]98.697.6
Ross(n= 8523) [2]96.293.9
EndocarditisARISE96.4 (1.6)n.a.
All DAH97.8 (0.9)92.6 (3.1)
Ross10098.6
Rossn.a.n.a.
Explantation/Re-operationARISE93.5 (2.1)n.a.
All DAH92.4 (1.7)69.5 (6.5)a
Ross97.194.2
Ross(n= 6653) [2]92.180.9
Major bleedingARISE98.6 (1.0)n.a.
All DAH99.4 (0.4)98.8 ± 0.9
Rossn.a.n.a.
Rossn.a.n.a.
Thrombotic event/strokeARISE99.3 (0.1)n.a.
All DAH99.7 (0.3)94.4 (5.1)
Ross100100
Rossn.a.n.a.
a

Freedom from explantation in all adult patients within the ARISE Registry was 72.8% (SD 10.0).

SD: standard deviation; n.a.: not available.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close